In this role, Nord will work with Listen Technologies’ partners to sell the company’s audio and content solutions to their customer bases. He will also oversee Listen Technologies’ outside and inside sales teams.
A new approach, published in “Cell Reports,” to regenerate inner ear sensory hair cells is said to lay the groundwork for treating chronic noise-induced hearing loss by the company, Frequency Therapeutics, and its co-founders who are drawing on research from Brigham and Women's Hospital (BWH), Harvard Medical School, Mass Eye and Ear Infirmary, and MIT. The program is expected to progress to into human clinical trials within the next 18 months.
Human beings are social creatures. This special report, featuring comments from leading experts in psychology and audiology, reviews new and important research on hearing loss, and shows why audiological care needs to renew its focus on helping patients regain their communication and social engagement activities—those things that make life meaningful and rewarding.
The Earlens Contact Hearing Solution has been shown to deliver greater audibility across an extended frequency range than conventional aids, but do patients notice the difference? A pilot study using a new questionnaire was run with experienced hearing aids users to evaluate the subjective sound quality they had when fit with the Earlens Contact Hearing Solution versus when they were switched back to their own acoustic hearing aids.